Latest filing published 31 Jul 2025 for Royalty Pharma plc.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Filings by Elizabeth H. Weatherman span 11 companies, the busiest being Wright Medical Group N.V., Nevro Corp and Vapotherm Inc. We count 181 filings; the first trade dates from 13 February 2006 and the latest from 31 July 2025.
Market trades split into 13 purchases (€3.4M) and 26 sales (€372.9M). The net balance comes to €369.5M on the selling side. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 112 share grants and 8 option exercises.
A typical purchase (the median) is worth €133k. Of 13 purchases, 13 formed part of a group of insiders buying within 30 days of each other. Purchases made close together by different insiders form what is called a cluster.
Most recently, on 31 July 2025, the filings show a share grant in Royalty Pharma plc. The latest purchase dates back some time: it was published 1,348 days ago, on 14 February 2023. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 55 declarations